Webinar series – Routes to address the real challenges in serialisation
With a counterfeit drug market now estimated at $200bn, many countries are putting serialisation legislation in place.In this three part webinar...
NEW VIDEOS SHOWCASING OUR CAPABILITIES NOW LIVE
July 2016: Aesica Pharmaceuticals, the global pharmaceutical contract development and manufacturing organisation (CDMO) is pleased to release their...
DEV610 Update
Consort Medical plc is pleased to provide a progress update on Bespak’s DEV610 development programme, for a proprietary dry powder inhaler...
Aesica meets the serialisation challenge – novel modular solution complies with all the world’s differing regulations
The CDMO leads the market with a flexible, fast, single platform for regulatory compliance across multiple geographies May 2016: Aesica...